Can Cannabis Reduce the Need for Benzodiazepines in Panic Disorder Patients?

PostedMarch 3, 2026

UpdatedMarch 3, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

For individuals with panic disorder , evaluating cannabis vs benzodiazepines for panic may offer insights into alternative treatment approaches. Some patients explore cannabis as a benzo replacement to reduce reliance on prescription medications.

Exploring Treatment Alternatives

Understanding cannabis vs benzodiazepines for panic can help guide patients and clinicians in choosing safer, effective strategies.

Anxiety Medication Alternative

Cannabis may serve as an anxiety medication alternative, offering symptomatic relief for panic episodes without the sedative effects of benzodiazepines.

Dependence Reduction

Transitioning to cannabis can contribute to dependence reduction, potentially lowering the risk associated with long-term benzodiazepine use.

Symptom Management

Careful monitoring of panic symptoms ensures that benzo replacement with cannabis provides adequate relief while avoiding overuse or adverse effects.

Comparative Considerations

While cannabis vs benzodiazepines for panic offers a possible alternative, patients should consider individual response, dosage, and professional guidance to balance effectiveness and safety.

Cannabis may help reduce the need for benzodiazepines in panic disorder through benzo replacement with cannabis, acting as an anxiety medication alternative and supporting dependence reduction. Professional oversight is crucial to ensure safe, effective management of panic disorder symptoms.

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.